Skip to content

ASYLIA DIAGNOSTICS

Active
Private limited companyfounded 20197 years activePhilipssite 5, 3001 Leuven, BelgiumKBO/BCE: BE 0732.783.629
Summary

The computed 12-month bankruptcy probability of ASYLIA DIAGNOSTICS is 3.8% (moderate). The annual accounts of ASYLIA DIAGNOSTICS for fiscal year 2024 show a net loss of 63% of the equity at the start of that year. The 2024 annual accounts show equity of €109,193 and a net result of -€183,907. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 22% of 635 sector peers (NACE 72, fiscal year 2024). The company has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals.

Overview

Activity
Research and development on biotechnology
NACE 72101
1 site
Size
€552,090total assets 2024
Equity
€109,193
Loss
-€183,907
Turnover not published (abridged schema)
Financial health
47 Fair Checked score 2024
Bankruptcy probability, 12 months
3.8%
Structure
Accounts 68 days overdue0 of 3 deeds read
Why 47- Figures for FY 2024 (filed 08-07-2025)- 1 change of registered office in 24 months- Loss of €183,907, the second in a row (FY 2024)+ Sector Scientific research and development (NACE 72)Show the evidence

Checked score

Score 2024
47 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 24% of its sector peers (NACE 72, micro)
Financial strength · tick = 2023
Weak
Solvency 45-21
equity 19.8% of total assets
Liquidity 55-3
short-term debt 6.2% · cash 4.1%
Profitability 0=
return on assets -33.3%
Bankruptcy probability, 12 months
3.8% Moderate
0%0.5%1.5%4%10%≥ 25%

About 4 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (934 companies)
Last 24 months 11-2024: 0.4% 12-2024: 0.4%● unchanged vs 11-2024 01-2025: 0.4%● unchanged vs 12-2024lowest value 02-2025: 0.4%● unchanged vs 01-2025lowest value 03-2025: 0.4%● unchanged vs 02-2025 04-2025: 1.0%▲ +0.6 percentage points vs 03-2025 05-2025: 0.9%▼ -0.1 percentage points vs 04-2025 06-2025: 1.0%▲ +0.1 percentage points vs 05-2025 07-2025: 1.0%● unchanged vs 06-2025 08-2025: 1.0%● unchanged vs 07-2025 09-2025: 1.0%● unchanged vs 08-2025 10-2025: 1.0%● unchanged vs 09-2025 11-2025: 0.9%▼ -0.1 percentage points vs 10-2025 12-2025: 0.9%● unchanged vs 11-2025 01-2026: 0.9%● unchanged vs 12-2025 02-2026: 0.9%● unchanged vs 01-2026 03-2026: 0.9%● unchanged vs 02-2026 04-2026: 1.0%▲ +0.1 percentage points vs 03-2026 05-2026: 1.0%● unchanged vs 04-2026 06-2026: 1.0%● unchanged vs 05-2026 07-2026: 1.1%▲ +0.1 percentage points vs 06-2026 08-2026: 1.7%▲ +0.6 percentage points vs 07-2026 09-2026: 2.2%▲ +0.5 percentage points vs 08-2026 10-2026: 3.8%▲ +1.6 percentage points vs 09-2026highest value
Credit up to €5,000 at 30 days only on tighter terms
Net loss of at least half of total assets or of the equity at the start of the financial year.
Liquidity ample (current ratio 13.96 against 27.56 in 2023; short-term debt: 6.2% and cash: 4.1% of total assets), but 80.2% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro): better than 29% on solvency, 42% on liquidity, 10% on profitability and 13% on growth.

The bankruptcy probability was computed on 06-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Seven signals.
−lowers risk+raises risk○neutral
raises risk · Figures for FY 2024 (filed 08-07-2025)
NBB · annual accounts
raises risk · 1 change of registered office in 24 months
Belgian State Gazette
lowers risk · Sector Scientific research and development (NACE 72)
KBO
raises risk · Loss of €183,907, the second in a row (FY 2024)
NBB · annual accounts
raises risk · Persistent losses
Two consecutive loss-making years (2023 and 2024); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2024
Net result per financial year
2021222324
2020 to 2024 · latest year -€183,907
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 22% of 635 sector peers (2024).
NBB · sector comparison
Position among 635 sector peers
Solvency
better than 22%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 04-07-2025, 27 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
not confirmed
2024
27 days early
2023
8 days late
2022
10 days late
2021
16 days early
2020
3 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 5 accounts on average 6 days before the deadline; the sector median for financial year 2024 is 13 days before the deadline, and 32% of the sector filed late.

Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
Checked from 2021 on.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2024 · micro…
  2. Weakest financial yearnet -€183,907
  3. Annual accounts filedfiscal year 2023 · micro…

Key points

  • Caution: Among the weakest 5% on net resultsector median €30,943 · 637 companies -€183,907 View
  • Caution: Equity fell in 2024from €293,100 to €109,193 ▼ 62.7% View
  • Caution: Accounts not fileddeadline was 31-07-2026 68 days late View
  • Caution: 2 loss-making years in a rowloss fiscal year 2024 -€183,907 View

By topic

Financials

Fiscal year
2024
Total assets
€552,090
Loss
-€183,907
Solvency
19.8%
Total assets▼ 23.1%
Net result
20202024
Go to Financials

Timeline

Events
12
Since
2021
  1. 10-08-2023Annual accounts filed
  2. 31-12-2022Back to profit
  3. 31-12-2022Liquidity times 6
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Research and development on biotechnologyNACE 72101
Founded
22-08-2019
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.